FDA Inspection
Sombra Cosmetics, IncSombra Cosmetics, Inc – FDA Inspection, Aug 26, 2016
Record Details
This FDA Inspection record concerns Sombra Cosmetics, Inc, with an inspection on August 26, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sombra Cosmetics, Inc
- Inspection Date
- August 26, 2016
- Product Type
- Drugs
View Company Profile
ID · b8e7ee95-42fc-4234-8b18-8ee046477d53
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 988071
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sombra Cosmetics, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2026 | Not classified | Denver District Office | Drug Quality Assurance |
| July 26, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sombra Cosmetics, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.